Skip to main content
. Author manuscript; available in PMC: 2012 Sep 13.
Published in final edited form as: Mol Cancer Ther. 2009 Apr;8(4):742–753. doi: 10.1158/1535-7163.MCT-08-0668

Figure 2.

Figure 2

mTORC1 inhibition after treatment with RAD001 or raptor siRNA has differential effects on the phosphorylation of AKT substrates. Cells were either treated with 20 nmol/L RAD001 for 48 h (A) or transfected with raptor (B) or rictor (C) siRNA for 72 h. Total protein extracts were analyzed by immunoblot for phosphorylation of the AKT substrates—GSK3β, FoxO1/3a, and TSC2.